Covington partnered with Gravity Diagnostics, CTI, Bexion, BioWish on Life Sciences Lab in state budget
Bexion Pharmaceuticals began in 2006 with two researchers, shards of incredible data, and an almost fantastical idea. Many years later,…
BXQ-350
Read More
‘I Thought It Was a Miracle’ – Clinical trial using Bexion BXQ-350 works wonders for Markey patient
By Allison Perry University of Kentucky Despite the leaps and advances made in cancer treatments over the past few decades,…
Bexion Pharmaceuticals announces significant regulatory milestone toward Phase 2 cancer trial
Covington-based Bexion Pharmaceuticals, Inc. an oncology-focused company, Tuesday announced the completion of a Type B End-of-Phase 1 meeting with the…
Bexion Pharmaceuticals announces the opening of study using BXQ-350 in treatment of rare tumors
Covington-based Bexion Pharmaceuticals, Inc., a clinical stage oncology company, has announced the initiation of an open-label Phase 1 Safety Study…
Bexion Pharmaceuticals, Inc. announces data from ongoing Phase I BXQ-350 clinical trial
Covington-based Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on rare brain and solid tumors, discussed data from 17 patients…